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MOBILE and the provision of total joint
replacement
Paul Dieppe, Diane Dixon, Jeremy Horwood, Beth Pollard, Marie Johnston on behalf
of the MOBILE research team
Department of Social Medicine, University of Bristol, Bristol, UK
Modern joint replacements have been available for 45 years, but we still do not have clear indications for these
interventions, and we do not know how to optimize the outcome for patients who agree to have them done. The
MOBILE programme has been investigating these issues in relation to primary total hip and knee joint
replacements, using mixed methods research.
There have been five main strands:
(1) Epidemiological investigations to find out who is receiving total hip and knee replacements in the National
Health Service (NHS). This has shown that there are extensive variations in different regions of the UK, with
inequalities and probable inequities in the provision of these operations;
(2) Epidemiological work to ascertain the population-based needs for the operations, showing under-provision
of knee joint replacements, and a relative reluctance of both patients and GPs to consider knee surgery;
(3) Quantitative and qualitative research into the views of patients, health care professionals and the public on
the indications for, and prioritization of, total hip and knee joint replacements. This has shown lack of
agreement within or between professional groups, as well as a mismatch between the views of patients
and the public, and those of professionals;
(4) Theoretical and experimental work on patient-related outcome measures, and the development of new
instruments to assess both pain and function in people with osteoarthritis, based on the International
Classification of Function, as well as a new integrated model of function;
(5) Cohort studies of patients undergoing hip or knee joint replacements to find out what the determinants of
good and bad outcomes are. These studies have emphasized the huge variation in disease severity at the time
of surgery.
The challenge now is to use and implement our findings for maximum patient benefit.
Introduction: what questions does this
programme address?
One of the first research programmes to be core funded
within the MRC HSRC was on the provision of total
joint replacements (TJR). The work was approved by
MRC in 1999 and initially led by a multidisciplinary
team drawn from the collaboration, including Linda
Davies (health economics), Paul Dieppe (rheumatology
and health services research), Jenny Donovan (social
science), Matthias Egger (epidemiology and statistics),
Paul Gregg (orthopaedic surgery) and Marie Johnston
(health psychology).
Initially we set out to answer two main questions:
(1) What should the indications for a total joint
replacement be in someone with osteoarthritis of
the hip and/or knee?
(2) How can we optimize the outcomes for people
with osteoarthritis who undergo a total joint
replacement?
Although high quality clinical trials are difficult to do in
this area, we realized that such trials might be needed to
provide definitive answers to the questions posed; there-
fore, our first programme was entitled ‘Towards Trials
of Total Joint Replacement’. Subsequently it became
clear that our questions were inextricably linked to an
understanding of musculoskeletal pain and disability
in older people, so in the second quinquennium we
combined the total joint replacement work with Shah
Ebrahim’s programme on mobility in the over-65s to
form the MOBILE research project, led by Paul
Dieppe, Shah Ebrahim and Marie Johnston.
What was known about this subject
10 years ago?
Modern joint replacement surgery was introduced by
the pioneering hip prosthesis work of Sir John
Charnley in the 1960s.1 It was immediately clear that
these hip replacements could revolutionize the lives of
people with severe arthritis, removing their pain and
restoring mobility. However, although Charnley’s
overall results were good, it soon became apparent
that infections and prosthesis loosening could also be
major problems following joint replacement. The sub-
sequent introduction of knee replacements, which
initially had relatively poor outcomes, resulted in the
technical issues of prosthesis design, bone fixation,
early and late loosening, and sepsis coming to the top
of the research agenda. Prosthesis designs (particularly
for the knee) soon improved, and so did outcomes.
Although trials of TJR were never undertaken, the
results of cohort studies, along with the testimonies of
countless patients and health care professionals, led to
the widespread belief that total hip or knee joint re-
placements are safe, effective procedures.2
However, the surgeons remained preoccupied with
the technical issues of prosthesis design, surgical pro-
cedures, prosthesis loosening and infection, rather
than patient outcomes. Furthermore, the patient
outcome measures being used most often in surgical
practice, such as the American Knee Society scoring
system or Harris Hip Score3,4 had not been properly
validated, and they mixed different types of measure,
summing scores that came from patient report and
physician examination, for example.
The demand for hip and knee replacements
increased greatly in the 1980s and 1990s, resulting in
extensive waiting times for patients. In spite of ‘political’
concern about this, surprisingly little research work was
undertaken on the indications for TJR or on patient
outcomes. Some consensus statements, based largely
on the views of surgeons, were published;5 in Canada
and New Zealand more formal attempts to aid patient
prioritization were undertaken;6,7 and in the USA one
of the ‘PORT’ (patient outcomes research teams)
studies addressed knee replacement.8 In Scandinavian
countries, joint replacement registries were set up,
largely to track the numbers of procedures being under-
taken in different units and to relate late loosening (or
prosthesis failure) to the design of the prostheses.9,10
But the research field was, and still is, heavily dominated
by the work of the materials scientists and engineers
who, along with the surgeons, are continually trying to
improve the design and longevity of their prostheses.
So, at the end of the 20th century, when we began our
work, TJR was already a very high volume, expensive,
high profile medical intervention throughout the
developed world. It was known that some 80% of
these procedures were done for people with osteo-
arthritis (OA), and that most, but not all patients were
pleased with the results. However, there were big gaps
in our understanding of who was getting a TJR and
why, or who should be offered these interventions,
and how good patient outcomes after hip or knee repla-
cement really were. We knew very little about how we
should be assessing outcome, and patients’ perspectives
had not been investigated. Furthermore, research was
not being undertaken in the UK on the process of
care relating to TJR, or on how the experience and out-
comes for people undergoing these operations might be
improved.
Therefore, when the HSRC was set up, primary joint
replacement for OA of the hip or knee seemed to be an
ideal context for multidisciplinary health services
research, and one that might provide generalizable
insights into key factors determining the ‘effectiveness,
efficiency and experience’11 of major health care inter-
ventions within the NHS.
What has the programme achieved?
We began with literature reviews and a theoretical con-
sideration of the pathways to joint replacement in the
UK, including the factors that might affect indications
and utilization.12 We have based much of our thinking
and work around this framework (Figure 1), and it led
to the development of four main strands within our
subsequent work:
Figure 1 The patient pathway
(1) Epidemiological work asking two main questions:
† Who is the NHS providing TJRs for at present,
and what trends are there in provision?
† What are the population-based needs for TJRs in
England?
(2) Quantitative and qualitative work to investigate
the views of patients, professionals and the public
on their experiences of services, on indications
for and prioritization of joint replacement, and
more recently on the experience of waiting for a
TJR;
(3) Theoretical and practical work on patient-related
outcomes, and the measures being used to assess
clinical outcomes after TJR, leading to the develop-
ment and validation of new instruments and
further theoretical developments in the disability
field;
(4) Cohort studies of patients undergoing TJRs,
designed to help study their outcomes and
uncover the determinants of relatively good or
bad results.
However, one of our main aims has been to develop a
genuinely multidisciplinary research programme in
which the different disciplines and projects contribute
to answering the questions posed. So a key issue for
the research team has been finding ways to bring these
different strands of work, dominated by different
disciplines, together to further equitable, effective and
efficient provision of TJRs in the NHS.
Epidemiology
The provision of TJRs in the English NHS
We used the Hospital Episode Statistics (HES) database
to investigate current and likely future provision of TJRs
in England, and to investigate some aspects of equity in
provision and determinants of bad outcomes.
The ‘headline’ findings were:13–15
† that rates of provision of TJR in England are conti-
nuing to rise, particularly for primary knee joint
replacements and revision hip joint surgery. Knee
joint replacement will soon become a higher
volume intervention than hip replacement
(the most recent HES data shows this has now
happened);
† more older people are receiving joint replacements
than was the case 10 years ago;
† age/sex standardized rates of surgery vary by 25–
30% between the different health regions of
England, with marked differences in sex ratios in
different areas, raising concerns about possible
inequities and inequalities in provision;
† adverse outcomes are less likely to occur in
high volume surgical units and in units that do
surgical training, suggesting the need for more
standardization of procedures and centralization of
services in England.
Population-based needs assessments
Coverage of the ‘political’ aspects of TJR, referred to
above, sometimes implies that there is a bottomless pit
of need, and that services could never cope with the
numbers of people who might benefit from such inter-
ventions. This is obviously nonsense, but there had
been almost no empirical work done on population-
based needs for these procedures in the UK, and
those who are responsible for delivering services need
such information. We used the Somerset and Avon
Survey of Health data-set (SASH) to investigate
this.16,17 The SASH cohort is a cross-sectional survey
of a stratified (according to the UK population)
random sample of 28,080 individuals aged 35 years
and over; from the data obtained in this cohort we esti-
mated the requirement for joint replacement on the
basis of levels of pain and activity ability (based on the
New Zealand priority scoring system – NZ score7),
adjusting for evidence of co-morbidity and treatment
preferences. We chose the NZ score not because it was
well validated as a priority scoring instrument, but
because it was the only one available.
We found:
† very little mismatch between the estimated need for
and the amount of total hip replacement in the late
1990s (both around 45,000/annum);
† a much greater mismatch between the need for and
provision of total knee replacements at the same time
(estimated need around 55,000/annum compared
with provision of around 30,000/annum);
† differences in the willingness to undergo surgery –
more people with a given level of disease were
willing to have a hip replaced than a knee;
† important gender differences in the provision of
care, women being less likely to have received drug
therapy, been referred for specialist care or con-
sidered for joint replacement than men. These
differences remained after adjustment of the data
for co-morbidities and willingness to undergo
surgery, and suggest that there may be important
issues of sex discrimination in primary care.
Taken together these data emphasize the importance of
the provision of hip and knee joint replacements to the
NHS, but also indicate that there are significant pro-
blems to be addressed; it would appear that both the
public and health care professionals need more help
to ensure equitable access to, and provision of, joint
replacements.
The views and experiences of patients,
professionals and the public
The stakeholders involved in TJR include the patients,
the doctors whom they first seek help from and who
may refer them to the surgeons, and the surgeons them-
selves, as well as the general public who are taxed to
provide the money for these interventions. We tried to
gain a better understanding of the views of each of these
groups about the provision of TJR for people with OA.
General practitioners: Both our theoretical and epide-
miological work on access to TJR emphasized the
importance of the ‘gatekeeper’ – the person who con-
trols access to orthopaedic surgeons. In the UK this is
largely the general practitioner (GP). Therefore, we
thought it important to obtain data from GPs and
other professionals that refer patients on what they
thought about the indications and priorities for
surgery. Within the ‘EUROHIP’ project we have under-
taken a survey of the views of 304 orthopaedic surgeons
and 314 referring physicians.18,19 Worrying differences
in views both within and between groups emerged. One
of the important findings within the data was the fact
that, in general, the referring physicians had a higher
threshold of disease severity for the consideration of
TJR than the surgeons. This suggests that some
people who the surgeon would consider appropriate
for an operation are not being referred because the
GP does not think they are severe enough.
As part of her PhD work, Caroline Sanders inter-
viewed 11 GPs.20 She found that they tended to
explain the occurrence and progression of OA as a
form of ‘wear and tear’ often associated with normal
aging, a similar view to those of the people living with
OA interviewed by Sanders.21,22 Although keen to
harness the self-help capacities of their patients, GPs
also seemed to make assumptions about what treat-
ments specific groups of patients would want or not
want, often assuming that older people might not
want surgery. This is worrying, as expectations and
assumptions about illness and disability in older age
are known to influence treatment trajectories, and the
views of the GPs involved in this study indicated that
some patients might have had unmet needs for treat-
ment. In relation to referral for surgery, the GPs
wanted to be able to use scoring systems (such as the
NZ score referred to above), to help them gain objective
data on the need for referral.
Patients: Caroline Sanders, and another PhD student
funded by the HSRC, Gillian Woolhead, also examined
the views of patients on the indications and priorities for
joint replacement. They found evidence for unmet need
in the community,21,22 identifying three main barriers
to access: people’s own perceptions of need and risk
leading to reluctance to seek help; negative experiences
in primary care (such as being told that ‘nothing can be
done’ about their arthritis); and previous experiences of
treatment in secondary care resulting in undue worries
about outcomes. These findings have recently been
reinforced by work done by Jiri Chard for his
HSRC-based PhD thesis, which highlighted the import-
ance of negative views among health care professionals
about OA and its treatment as a barrier for both patients
and professionals to the provision of timely TJRs.23
Woolhead also explored what patients thought was
happening in terms of the prioritization of individuals
for a TJR, contrasting this with what they thought
should happen,24 and found that patients, like the
health care professionals, think that pain and disability
should be the key criteria, but that they had additional
issues that they thought the professionals should,
but were not taking into account; these included the
length of suffering, paid employment and the
payment of National Insurance contributions, and
caring for dependants. The patients that Woolhead
interviewed thought that the doctors took too much
notice of age, weight and excessive complaining by
other patients. Woolhead also talked to some of her
patients after they had had a total knee replacement
to find out what they made of the experience and
outcome.25 She reported that most of them struggled
to make sense of what had happened and while publicly
reporting good outcomes, many privately admitted that
they still had a good deal of pain in the operated knee,
with associated disability. Furthermore, many of those
with ongoing pain blamed themselves, thinking that
they must either have done too much or too little exer-
cise in the immediate postoperative period. This work
highlighted another problem experienced by patients
undergoing a TJR in the UK: the lack of clear guidance
on postoperative activity/exercise levels.
Surgeons: Nicola Hobbs is currently using patient
vignettes to examine the factors that influence surgeons’
prioritization for hip replacement surgery, asking them
to rank patient vignettes that differed in level of pain
severity, activity limitations, participation restrictions
and patient motivation. Pain was more influential than
either activity limitations or participation restrictions,
but patient motivation was more influential than any-
thing else in determining their hypothetical prioriti-
zation of patients for surgery. Next we will undertake
in-depth interviews of orthopaedic surgeons, along
with observational studies of consultations between sur-
geons and patients about the possibility of a primary
TJR.
This body of work has highlighted several areas of
concern, including a number of barriers to access, a mis-
match within and between the views of the public,
patients and health care professionals on the indications
for a TJR, and patient prioritization. It seems likely that
these problems result in serious inequities in provision
in the UK. But the work has also suggested some possi-
ble solutions, such as working with the ‘capacity to
benefit’ idea, as outlined further below.
Measurement of outcomes in TJR
In order to be able to accurately evaluate the outcomes
of TJR and understand the processes involved, it is
important to use appropriate measurement instru-
ments. A measure that defines the construct of interest
enhances compatibility, comparisons and understand-
ing between studies. In order to change or manipulate
something, it is necessary to understand how it operates.
Hence, it is advantageous if a measure is assessing
a construct that is part of a theoretical model. A major
strand of the MOBILE programme, led by Marie
Johnston and her colleagues Beth Pollard and Diane
Dixon in Scotland, is designed to make more sense of
the theory and practice of health status and outcomes
measurement for people with OA undergoing a TJR.
This work has primarily focused on self-report
methods, but has also involved direct observation,
proxy reports and electronic measurement of activity
using accelerometers.
A review of existing commonly used measures
to assess OA found wide variation in methodological
development and little relationship to theoretical
models.26 While patient self-reported measures had, in
general, good methodological development, the
review highlighted the relatively poor development
of clinician-reported measures.
The International Classification of Functioning,
Disability and Health (ICF27) has become widely
adopted as the theoretical framework of choice. The
ICF is based upon a biopsychosocial model of function-
ing and has three main components: impairment (I);
activity limitation (A); and participation restriction (P).
In examining the relationships between I, A and P, it
is important to establish that each measure is assessing
only a single theoretical construct and not other
constructs; otherwise, observed relationships between
constructs may be misleading and interventions may
be inappropriately targeted. Work by Beth Pollard
has shown, based on classifications by expert judges,
that existing OA measures contain a mixture of
ICF constructs28,29 and are, therefore, unsuitable for
investigations based on the ICF.
However, a pool of ‘uncontaminated’ items was
identified by the expert judges; i.e. items that were
measuring a single ICF construct. These ‘uncontami-
nated’ items formed the basis of new measures of the
ICF components of impairment, activity limitation and
participation restriction. The items were examined
using responses from a geographical cohort of patients
(JR-600 – see below) shortly before and 12 months
after having a hip or knee replacement. Item analysis
of the preoperative data was carried out combining
item response theory and classical test theory
methods, and led to the removal of items that did not
fit. The new measures appear to provide a more accu-
rate estimation of the ICF pathways than pre-existing
measures,30 and they are currently undergoing
further refinement and empirical testing. Additionally,
the use of these measures of impairment, activity limi-
tation and participation restriction, is currently being
explored postoperatively.
Findings of relevance to the assessment of outcomes
in TJR include:
† existing measures of outcome in OA and TJR assess
a mixture of impairment, activity limitation and
participation restriction and are, therefore, unsuitable
for measuring ICF constructs;
† using the method of Discriminant Content
Validity,28 it is possible to identify questionnaire
items which are ‘uncontaminated’ by the other
constructs and to develop new, pure measures;
† self-report, proxy report, observation and accelero-
meter assessments of disability are correlated,
but do not show sufficient agreement to be used
interchangeably;31
† all methods of measurement showed some corre-
lation with negative mood, i.e. negative affectivity
bias is not restricted to self-report;31,32
† in people who report activity limitations which do
not accord with their underlying impairment,
those reporting unexpectedly low activity levels
give a more accurate representation of their true
levels (measured by accelerometers) than those
reporting unexpectedly high levels of activity (work
with Derek Johnston and Julia Hay).
In collaboration with an international group of investi-
gators, working under the auspices of the Osteoarthritis
Research Society International (ORSI) and the Outcomes
in Rheumatology Group (OMERACT), we have also been
looking at the measurement of pain in OA.33 The main
contributors to this from the MOBILE group have been
Rachael Gooberman-Hill and her PhD student Fiona
Mackichan. They carried out focus groups with patients
with hip or knee OA of varying severity,34 and using the
‘questerviews technique’,35 (a methodological approach
developed within the HSRC), sought their views on
the questions used to assess pain impairment and
resulting activity limitations within the WOMAC, the
most commonly used outcome instrument in studies
of OA.36 Findings of relevance to the assessment of pain
included:
(1) pain is intermittent and variable, so the recording
of severity on a pain measure will depend entirely
on when the question is asked;
(2) pain elsewhere in the body is common and influ-
ences the experience of joint pain, so it is naı¨ve to
ask about pain in a single joint in isolation;
(3) pain and function cannot be separated as is
attempted in most standard measures, as the
amount of pain depends largely on what a
person does;
(4) further to the above, adaptation and avoidance
strategies are very widely used by patients and
these modify the pain experience; and
(5) in addition to their ‘usual’ aching activity-related
pain, most people with hip or knee OA experience
spontaneous, short-lasting episodes of a more
severe form of joint pain.
These findings, and other work from the wider
OARSI/OMERACT group, have led to the develop-
ment of a new instrument that takes account of ‘usual’
pain, as well as episodic attacks, avoids muddling
pain with function and tries to assess pain distress
as well as pain severity. The instrument is currently
being validated.
Paul Dieppe and his PhD student Vikki Wylde are
developing further work on pain in OA. The finding
that many patients experience spontaneous attacks of
pain, as well as other published work, suggests that
central pain sensitization mechanisms (in the spinal
cord or brain) may be as important as local pain
driven from the joint. So we are now using quantitative
sensory testing (QST) combined with detailed pain
histories, to try to identify patients in whom pain sensiti-
zation might be of paramount importance. We hypothe-
size that such patients would respond relatively poorly
to a TJR (Dieppe et al., submitted for publication).37
Theory
The measurement work has highlighted the lack of
theory underpinning existing measurement instru-
ments and understanding of the process of disablement.
The use of measures that have a theoretical foundation
should lead to more accurate evaluations of health
outcome before and after TJR. In addition, we have
worked to develop the ICF from a taxonomy of health
outcomes to an explanatory model of disability. The
ICF suggests a pathway from pain impairment to
activity limitations to participation restriction. This
pathway is represented in patients’ spontaneous
reports. Patients were asked what were the three most
important things they hoped for from their joint re-
placement. Their responses were classified according
to the main ICF components (impairment, activity limit-
ation and participation restriction). The most common
pattern of responses was that the patients’ first hope
related to impairment (e.g. ‘I want to be pain free’),
their second hope related to activity limitation (e.g.
‘easier walking’) and their third hope related to partici-
pation restriction (e.g. ‘to be able to play golf’). Thus
patients’ comments appear to fit the ICF modelling
approach.
However, we have additionally attempted to build on
that model by incorporating psychological constructs.
The activity limitations and participation restriction
constructs in the ICF are forms of human behaviour
and, therefore, invite the application of theories of beha-
viour and behaviour change to further our understand-
ing of the processes that influence disability. We have
incorporated models of behaviour, such as Social
Cognitive Theory38 and the Theory of Planned
Behaviour,39 into the ICF to develop an integrated
model of disability (‘disability as behaviour’40
(Figure 2). In this integrated model, psychological
theory can be seen to operationalize the ‘personal’
factors construct in the ICF. Consequently, psychologi-
cal factors mediate the relationship between impair-
ment, activity limitations and participation restrictions.
We have employed structural equation modelling
to test the ability of the integrated model to account
for mobility disability in people awaiting TRJ using
a subset of patients from the JR-600 study. Diane
Dixon has tested the integrated model.
Findings of relevance to understanding the relation-
ships between pain impairment and walking disability
in OA included:
† the new ‘pure’ measures give stronger evidence of
the theoretical links between I, A and P than existing
‘contaminated’ measures;
† people awaiting TJR intuitively describe their goals
for surgery in terms of the ICF model – i.e. predomi-
nantly putting I first, followed by A, followed by P;
† the ICF model accounts for 28% of the variance in
walking limitations in patients with OA awaiting TJR;
† psychological theory accounts for 48% of the vari-
ance in walking limitations in patients with OA
awaiting TJR;
† the integrated model (ICF plus psychological theory)
accounts for 57% of the variance in walking limita-
tions in patients awaiting TJR;
† personal control cognitions significantly mediated
the relationship between impairment and activity
limitations indicating that interventions that target
such cognitions could contribute to optimal
recovery;
† I, A and P have varying impacts on patient distress
in different disabling conditions;41
† N of 1 methods can be used to test the ability of the
integrated model to explain disability within a single
individual (work by HSRC PhD student Francis
Quinn).
The ICF also recognizes that ‘environmental’ factors
influence the relationships between I, A and P. Future
work with the integrated model will incorporate measures
of the ‘environment’, in the form of socioeconomic status
and educational attainment, with the aim of improving
the explanatory power of the integrated model.
Cohort studies and the determinants of
good and bad outcomes after TJR
One way of finding out who will benefit most from an
intervention like a TJR is to undertake a clinical trial.
A waiting list trial, of the sort used to investigate
Figure 2 Integrated model of disability: the theory of planned
behaviour incorporated into the ICF. PBC, perceived behavioural
control
cataract surgery,42 is one option. As mentioned in the
introduction, when this programme of work began, we
had planned to do such trials, but we were unable to
obtain ethical committee approval, even to undertake
pilot studies. The main reason given was that everyone
‘knew’ that TJRs were effective and trials were not
necessary. So we have fallen back on cohort studies to
try to ascertain the determinants of good and bad
outcomes.
We began by looking at some existing databases, such
as the Avon Knee Registry,43 but these proved to be of
little value, because of the paucity of relevant baseline
data. So, we have developed two new cohorts of our
own:
(1) The ‘JR-600’ cohort: As the name implies, this is
a cohort of 600 people with OA, undergoing a
primary hip or knee replacement. It is based at
Dundee in Scotland, and Beth Pollard, Diane
Dixon, Marie Johnston and David Rowley are the
primary investigators. As mentioned above, it is
being used to investigate our new approach to
outcome assessment and to understanding activity
limitations within an integrated theoretical model.
The data collected contains a wealth of information
that should help us to uncover some of the factors
that determine good or bad outcomes. In particu-
lar, we have collected a large amount of infor-
mation on the psychological status of the patients
preoperatively as suggested by our integrated
theoretical approach;
(2) The ‘EUROHIP’ cohort: The ‘EUROHIP’ consor-
tium is led by Paul Dieppe, Wilfred von Eiff
(Munster) and Wolfhart Puhl (Ulm). It includes
20 orthopaedic centres in 12 different countries,
and has been investigating the indications,
process and outcomes of primary total hip replace-
ments.18,19 Paul Dieppe is the lead investigator of a
cohort study being undertaken by the group. Data
have been collected from 1520 patients, most of
whom have been adequately assessed both pre-
operatively and one year later. The data include
WOMAC and EQ5D at both time points, as well
as extensive preoperative data on demography,
co-morbidities and social status. An initial analysis
of the baseline data has emphasized the huge varia-
tion in the severity of the disease at the preopera-
tive assessment. Educational status was one of the
strong predictors of disease severity; those who
were more educated having significantly less
severe disease at the time of surgery than those
with lower educational attainments. We will be
undertaking analyses of the determinants of
outcome in this cohort soon.
In addition to the clinical data available in these cohorts,
we have radiographs, which are being assessed in a
uniform way by two assessors (Paul Dieppe and Sue
Williams) to help to relate structural damage to health
status and outcomes.
Bringing it all together, where this work
should go next
The MOBILE programme has been the vehicle for a
large body of work on TJR for OA of the hip and knee
in the UK. The work so far has highlighted four main
areas of concern:
(1) indications for surgery, prioritization and access;
(2) outcome assessment;
(3) how impairment combines with psychological
factors in the development of activity limitations;
(4) perioperative care.
Indications for surgery, prioritization and access
It is clear that there is confusion about who should be
considered for a TJR, with major differences in views
both within and between different groups of pro-
fessionals, and with patients and the public suggesting
approaches that are quite different from those of their
doctors. Furthermore, we have found a lot of evidence
for inequities in provision in England, and likely
inequalities – older people and women seem to be par-
ticularly likely to be treated ‘unequally’. The framework
that we started out with can now be improved upon with
data to support the existence of key barriers to access to
surgery (Figure 1).
How can the situation be improved? GPs are asking
for guidance on who they should refer to surgeons,
and are increasingly being asked to use crude scoring
systems such as the New Zealand priority score.7 But
such scores do not take account of the issues that
patients and the public think should be used when
trying to make such decisions (such as carer roles). We
are taking two different approaches to this:
(1) Appropriateness criteria: Appropriateness criteria
have been developed for a number of surgical
interventions, generally using the approach deve-
loped by the RAND organization.44 There have
been attempts to do this for joint replacement,45
and the EUROHIP consortium has recently pro-
duced new criteria that take account of a wider
spectrum of factors and are, we believe, an
improvement (Floren et al., submitted for publi-
cation). A way forward would be to adapt these
criteria locally with the help of patients as well
as professionals. We are recommending the use
of the data that we have, including both our appro-
priateness criteria, and the framework mentioned
below, by local consortia of patients and pro-
fessionals to aid shared understanding between
the ‘gatekeepers’, the surgeons, and health care
managers on referral and prioritization for TJR;
(2) A framework based on ‘capacity to benefit’: The views of
the public and of patients undergoing TJR indicate
that to them the answer is simple – ‘those people
who are going to gain the most from the interven-
tion are the ones that you should prioritize for
surgery’. Many of them seemed rather surprised
that we did not know who those people were!
Clearly our cohort studies, in addition to current
work in many other centres, should help to under-
stand the determinants of relatively good or poor
outcomes after surgery, and hence aid prioritiza-
tion by ‘capacity to benefit’ – a construct that
involves the value of alternatives and the risks
from surgical intervention as well as the likely
reduction in pain and disability. We are working
on populating and testing a framework for this
construct, which might be of value to both patients
and professionals (Figure 3).46
Outcome assessment
The majority of published work on the ‘success or
failure’ of a TJR is about technical prosthesis failure –
i.e. loosening or infection. Although things have
changed for the better over the last decade, this is still
the dominant paradigm in orthopaedics, in spite of
the fact that patient-related outcomes do not appear to
have much relationship to the technical outcome, at
least in the short term. We believe that a much more
sophisticated approach to outcome assessment is
needed to allow us to understand what is going on
and how to improve things for the patients. We hope
that our new measures of pain, impairment, activity
limitations and participation restrictions (the ICF
domains), mentioned above, will help this, and we
intend to promote their use in rheumatology and ortho-
paedics. In addition, we are applying this approach to
trials, re-analysing the effects of interventions to see if
they differentially affect I, A and P. Our new measures
cannot be used for utility assessment, and we have not
looked into the issue of QUALs and the cost-
effectiveness of TJR; however, work within the linked
‘ICEPOP’ programme is developing that area, as
outlined by Coast et al. in this volume.47
How impairment combines with psychological
factors in the development of activity limitations
The work of Marie Johnston and her colleagues in
Scotland is leading to new ways of thinking about what
factors need to be considered to improve outcomes.
The ICF suggests relationships between impairment
and disability. The main pathways of the ICF
model have been explored using the newly developed
ICF measures (see above). Using data from the
JR-600 cohort, Marie Johnston, Beth Pollard and
Diane Dixon have shown that there are significant
pathways between impairment and activity limitation
and between activity limitation and participation restric-
tion, but a non-significant relationship between impair-
ment and participation restriction. These pathways
appeared to be consistent with the way patients
view their condition. Additionally, they suggest that
interventions aimed at reducing impairment should
also reduce activity limitation and participation restric-
tion, whereas an intervention aimed at improving
participation may not impact on the two other
components of the ICF.
We are currently testing the ability of the integrated
model of disability to account for recovery from TJR
in patients from JR-600 and in n-of-1 studies. These
analyses should also identify cognitions that predict
recovery of function. The JR-600 study should demon-
strate the ability of the integrated model to account for
differences between individuals within a group,
whereas n-of-1 studies should establish the ability of
the model to account for change within a single indivi-
dual. The concomitant use of these two methods
should, therefore, go some way to addressing the clini-
cians’ problem of applying outcomes generated from
groups of individuals in trials to specific patients.
The aim of this work is to promote optimal outcome
using interventions designed to impact on the cogni-
tions that predict outcomes and thereby enhance reco-
very, and to reduce activity limitations independently
of the need to reduce impairment. We are planning
studies that go through the stages of intervention deve-
lopment, based on the integrated model, and sub-
sequent evaluation in trials, for people in the
community with OA and also prior to TJR .
Perioperative care
Our work has highlighted a large number of concerns
about the process of TJR and patients’ experiences in
hospitals. In addition to the evidence for variations in
different regions, apparent in the HES data, our inter-
views with patients indicate that pain control is poor
and that they are given little or no advice or help with
postoperative activity. As a result of this work, we have
decided that perioperative care, including better
Figure 3 Preliminary conceptual model of a framework for the
‘capacity to beneﬁt’ from a total joint replacement
patient-centred approaches to preoperative prepara-
tion, perioperative pain control and postoperative
rehabilitation need to be a future priority.
We are currently undertaking literature searches con-
cerning the delivery of care related to TJR, and pre- and
postoperative pain control. There is little good trial
evidence to help professionals understand what they
should be doing, and the EUROHIP project has
shown that there are massive differences in approach
in the different participating countries and centres.
We believe that the way forward here is trials. We are
planning trials to aid pain control perioperatively, to
improve cognitions, and to improve general health
and musculoskeletal function perioperatively. We
have, in collaboration with Ashley Blom and Ian
Learmonth in the Avon Orthopaedic Centre in Bristol,
obtained NIHR programme grant funding to take this
work forward.
Conclusions
It is 45 years since Charnley published his paper
‘Arthroplasty of the hip: a new operation’ in the Lancet.1
The operation works well for most people. But we still
do not know who is likely to benefit most, and in whom
it will fail (clinically), or why. Until recently, very little con-
sideration was given to how to assess outcomes or how
they could be improved by optimizing perioperative
care. We believe that the MOBILE programme has pro-
vided data that give clear indications as to the ways
forward to improve the situation, at least in the UK.
The challenge now, as ever with multidisciplinary
HSR, is how to implement our findings for maximum
patient benefit. In that regard, we need the help of
policy-makers and managers within the NHS. It is clear
to us that although TJR is an important, effective and
cost-effective procedure, patient experiences and out-
comes could be improved, and inequalities reduced if we:
(1) made sure that joint replacements were only
carried out in high volume teaching units which
standardize their procedures;
(2) developed local consortia of health care pro-
fessionals from primary and secondary care,
along with patients who have had or need to have
a TJR, to develop local appropriateness criteria
for patients thought to be in need of a TJR, that
could be ‘owned’ by both local GPs and orthopae-
dic surgeons;
(3) developed evidence-informed consensus criteria
for standardized programmes of perioperative
care and rehabilitation that can be investigated
through clinical trials.
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